GEN-003 Vaccine (30μg of each antigen)

BIOLOGICAL2 trials

Sponsors

Genocea Biosciences, Inc.

Conditions

Genital Herpes Simplex Type 2

Phase 2

Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine

CompletedNCT02114060

Genocea Biosciences, Inc.Genital Herpes Simplex Type 2

Start: 2014-07-31End: 2016-02-29Updated: 2017-10-16

Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study

CompletedNCT02300142

Genocea Biosciences, Inc.Genital Herpes Simplex Type 2

Start: 2015-01-31End: 2016-06-30Updated: 2017-10-16